UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

The lancet oncology, 2016-12, Vol.17 (12), p.1683-1696

2016

Volltextzugriff (PDF)

Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

Investigational new drugs, 2018-02, Vol.36 (1), p.96-102

2018

Volltextzugriff (PDF)

MicroRNAs and cancer: past, present, and potential future

Molecular cancer therapeutics, 2008-12, Vol.7 (12), p.3655-3660

2008

Volltextzugriff (PDF)

miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

Journal of thoracic oncology, 2011-03, Vol.6 (3), p.482-488

2011

Volltextzugriff (PDF)

STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma

PloS one, 2012-02, Vol.7 (2), p.e30820-e30820

2012

Volltextzugriff (PDF)

Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic

PloS one, 2014-07, Vol.9 (7), p.e100244-e100244

2014

Volltextzugriff (PDF)

Predictable modulation of cancer treatment outcomes by the gut microbiota

Microbiome, 2020-03, Vol.8 (1), p.28-28, Article 28

2020

Volltextzugriff (PDF)

Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients

PloS one, 2021-11, Vol.16 (11), p.e0259898-e0259898

2021

Volltextzugriff (PDF)

Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions

Nature communications, 2023-05, Vol.14 (1), p.2673-2673, Article 2673

2023

Volltextzugriff (PDF)

BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity

PloS one, 2022-05, Vol.17 (5), p.e0266980-e0266980

2022

Volltextzugriff (PDF)

TMB or not TMB as a biomarker: That is the question

Critical reviews in oncology/hematology, 2021-07, Vol.163, p.103374-103374, Article 103374

2021

Volltextzugriff (PDF)

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status

Oncoimmunology, 2023-12, Vol.12 (1), p.2204746-2204746

2023

Volltextzugriff (PDF)

Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs

BMC genomics, 2013-05, Vol.14 (1), p.302-302, Article 302

2013

Volltextzugriff (PDF)

From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)

PloS one, 2016-01, Vol.11 (1), p.e0144797-e0144797

2016

Volltextzugriff (PDF)

Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer

Cancers, 2023-10, Vol.15 (20), p.5091

2023

Volltextzugriff (PDF)

A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges

PloS one, 2013-10, Vol.8 (10), p.e76438-e76438

2013

Volltextzugriff (PDF)

A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy

PloS one, 2017-11, Vol.12 (11), p.e0188628-e0188628

2017

Volltextzugriff (PDF)

KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures

Cancer treatment reviews, 2020-04, Vol.85, p.101978-101978, Article 101978

2020

Volltextzugriff (PDF)

Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication

PeerJ (San Francisco, CA), 2019-02, Vol.7, p.e6423-e6423, Article e6423

2019

Volltextzugriff (PDF)

Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)

Translational oncology, 2019-12, Vol.12 (12), p.1539-1548

2019

Volltextzugriff (PDF)

Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer

PeerJ (San Francisco, CA), 2019-07, Vol.7, p.e7232-e7232, Article e7232

2019

Volltextzugriff (PDF)

A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy

PloS one, 2017-06, Vol.12 (6), p.e0179170-e0179170

2017

Volltextzugriff (PDF)

Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

Investigational new drugs, 2019-08, Vol.37 (4), p.797-797

2019

Volltextzugriff (PDF)

Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2006-09, Vol.24 (27), p.4405-4411

2006

Volltextzugriff (PDF)

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(248)
Mit Volltextzugriff
(241)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(146)
Life Sciences & Biomedicine
(124)
Humans
(115)
Oncology
(96)
Male
(72)
Female
(70)
Middle Aged
(55)
Adult
(53)
Aged
(53)
Tumors
(43)
Neoplasms - Drug Therapy
(34)
Aged, 80 And Over
(30)
Treatment Outcome
(29)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Cancer
(25)
Cancer Therapies
(25)
Lung Cancer
(25)
Antineoplastic Agents - Therapeutic Use
(24)
Patients
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(46)
Cancer Research
(21)
Clinical Cancer Research
(16)
Plos One
(16)
Investigational New Drugs
(12)
Journal Of Thoracic Oncology
(12)
Molecular Cancer Therapeutics
(11)
Dermatologic Surgery
(5)
Cancer Chemotherapy And Pharmacology
(4)
Microrna
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial

Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

MicroRNAs and cancer: past, present, and potential future

miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer

STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma

Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic

Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein

Predictable modulation of cancer treatment outcomes by the gut microbiota

Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients

Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions

BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved anti-cell line derived tumor xenograft activity

TMB or not TMB as a biomarker: That is the question

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status

Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs

From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)

Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer

A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges

A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy

KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures

Discordant financial conflicts of interest disclosures between clinical trial conference abstract and subsequent publication

Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)

Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer

A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy

Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma

Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

Suchergebnisse filtern